Patents Assigned to Genovate Biotechnology Co., Ltd.
  • Crystals of hydroxychloroquine sulfate
    Patent number: 11578041
    Abstract: Two crystals of (S)-(+)-hydroxychloroquine sulfate. One crystal features diffraction peaks at 12.3±0.1°, 13.1±0.1°, 17.9±0.1°, 22.8±0.1°, 23.4±0.1°, 25.1±0.1°, and 26.3±0.1° as 2? angles in a powder X-ray diffraction pattern. The other crystal features diffraction peaks at 12.8±0.1°, 14.5±0.1°, 16.7±0.1°, 17.6±0.1°, 20.2±0.1°, 21.4±0.1°, 23.8±0.1°, 25.7±0.1°, and 26.0±0.1° as 2? angles in a powder X-ray diffraction pattern. Also disclosed are methods of preparing crystals of (S)-(+)-hydroxychloroquine sulfate.
    Type: Grant
    Filed: December 31, 2020
    Date of Patent: February 14, 2023
    Assignee: Genovate Biotechnology Co. Ltd.
    Inventors: Jen Chen, Nai-tung Yao
  • ANTIEMETIC PATCH
    Publication number: 20110218505
    Abstract: An antiemetic patch is provided. The antiemetic patch includes a backing layer, a release liner, and a matrix layer disposed between the backing layer and the release liner. The matrix layer includes an antiemetic composition, and the antiemetic composition includes an antiemetic agent ranged, a permeation enhancer and an adhesive.
    Type: Application
    Filed: November 26, 2009
    Publication date: September 8, 2011
    Applicants: GENOVATE BIOTECHNOLOGY CO., LTD., STANDARD CHEM & PHARM CO., LTD., JIANBO INTERNATIONAL DEVELOPMENT LTD.
    Inventors: Jui-Mei Lu, Lih-Hua Lian, Li-Fen Yao
  • Modulation of interleukin-10 by DHEA
    Publication number: 20050014734
    Abstract: Methods of modulating IL-10 levels in a subject through administration of DHEA are provided herein, as are methods of prophylactically and therapeutically treating medical conditions in a subject through modulating the subject's level of IL-10 with administration of DHEA.
    Type: Application
    Filed: July 18, 2003
    Publication date: January 20, 2005
    Applicant: Genovate Biotechnology Co., Ltd.
    Inventor: Deh-Ming Chang